Product Description
GLSAT-M2 Glimepiride And Metformin Hydrochloride Prolonged-Release Tablets IP are a combination of two medications that are used to treat type 2 diabetes. Glimepiride is a sulfonylurea that helps the pancreas to produce more insulin and Metformin Hydrochloride is a biguanide that helps to reduce the amount of sugar produced by the liver and improves the bodys sensitivity to insulin. These tablets are prolonged-release, which means they release the medication slowly over time, providing sustained blood sugar control throughout the day. They come in a dosage of 500 mg of Glimepiride and 500 mg of Metformin Hydrochloride and are suitable for all.
FAQs of GLSAT-M2 Glimepiride And Metformin Hydrochloride Prolonged-Release Tablets IP:
Q: What are GLSAT-M2 Glimepiride And Metformin Hydrochloride Prolonged-Release Tablets IP used for?
A: These tablets are used to treat type 2 diabetes.
Q: What is the dosage of the tablets?
A: The tablets come in a dosage of 500 mg of Glimepiride and 500 mg of Metformin Hydrochloride.
Q: How should I take these tablets?
A: You should take these tablets as per the suggestion of your doctor.
Q: How should I store these tablets?
A: These tablets should be stored in a dry place.
Q: What is the packaging quantity of these tablets?
A: These tablets come in a packaging quantity of 15*10 tablets per box.